Pathway | Target genes with pathway annotation | P-value | Pathway ID |
---|---|---|---|
Metabolic pathways | 1321 (12.44Â %) | 0.4507364 | ko01100 |
Pathways in cancer | 373 (3.51Â %) | 0.8069502 | ko05200 |
Biosynthesis of secondary metabolites | 367 (3.46Â %) | 0.8097889 | ko01110 |
Regulation of actin cytoskeleton | 337 (3.17Â %) | 0.8241077 | ko04810 |
MAPK signaling pathway | 322 (3.03Â %) | 0.8313458 | ko04010 |
HTLV-I infection | 297 (2.8Â %) | 0.8435271 | ko05166 |
Endocytosis | 292 (2.75Â %) | 0.8459811 | ko04144 |
Focal adhesion | 285 (2.68Â %) | 0.8494267 | ko04510 |
Tight junction | 266 (2.51Â %) | 0.8588381 | ko04530 |
Tuberculosis | 262 (2.47Â %) | 0.8608305 | ko05152 |
Phagosome | 251 (2.36Â %) | 0.8663294 | ko04145 |
Epstein-Barr virus infection | 244 (2.3Â %) | 0.869844 | ko05169 |
Neuroactive ligand-receptor interaction | 239 (2.25Â %) | 0.8723616 | ko04080 |
Cytokine-cytokine receptor interaction | 237 (2.23Â %) | 0.8733703 | ko04060 |
Influenza A | 236 (2.22Â %) | 0.873875 | ko05164 |